NCT05498220 2026-04-16Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell LymphomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Terminated5 enrolled 13 charts
NCT02983097 2018-01-19R²-DHAPGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHPhase 1/2 Terminated34 enrolled